IIT Bombay: blood test: IIT Bombay Develops Low Cost for Anaemia and Sickle Cell

Researchers at IIT Bombay have created a novel, low‑cost blood test that simultaneously screens for anaemia and sickle cell disease, providing a practical alternative to the expensive and complex laboratory methods currently used in many Indian hospitals. The diagnostic tool is designed to be simple enough for use in basic health centres, aiming to broaden access to essential screening for blood‑related disorders.

IIT Bombay affordable blood test

The new screening mechanism aims to streamline preliminary medical evaluations in public‑health settings, where traditional diagnostics often depend on specialized infrastructure that is scarce in remote or underserved regions. By eliminating the need for sophisticated equipment, the test can be deployed in community health camps and primary clinics, reducing logistical barriers and lowering the financial burden on patients and healthcare providers alike.

Wider adoption may improve early detection rates, enabling timely treatment and better health outcomes for vulnerable groups. The affordability of the tool also supports national efforts to combat widespread blood disorders and strengthen preventive healthcare infrastructure.

Also Read:

As the technology moves toward large‑scale validation studies, securing regulatory approval and establishing manufacturing partnerships will be crucial for rapid distribution. Observers will watch how quickly the screening tool transitions from academic research to widespread clinical use in hospitals and community health camps across the country. Successful rollout could set a precedent for affordable diagnostic innovations targeting other prevalent diseases in low‑resource settings.

For more news..

Leave a Reply

Your email address will not be published. Required fields are marked *